4D Molecular Therapeutics is a clinical-stage gene therapy company based in California that develops product candidates using adeno-associated viruses vectors. They focus on three areas of treatment, specifically ophthalmology, cardiology, and pulmonology, and have three product candidates in clinical trials and two IND candidates. The company also has research and collaboration arrangements with uniQure, CRF, Roche, and CFF.